Edwards Lifesciences | 当期純利益

株価
86.63
毎日の変更
0.73 0.85%
毎月
5.83%
毎年
20.96%
Q1 予測
77.31




当期純利益 変化する 日付
Abbott USD 1.78B 132M 2025-12
Artivion USD -2.29M 167K 2024-09
AtriCure USD 1.76M 2.02M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Cooper Companies USD 84.6M 13.7M 2025-09
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Hologic USD 179.1M 8.2M 2025-12
ICU Medical USD -15.73M 12.34M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
J&J USD 5.12B 36M 2025-12
Masimo USD -100.4M 151.7M 2025-09
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12


Edwards Lifesciences 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.